24 December, 2024

Singapore
SCG Cell Therapy signs MoU with A*STAR to accelerate RNA-based therapeutic development in Singapore

SCG Cell Therapy, a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and th...Read more

- 23 December 2024 News

China
Merck strikes partnership worth $1.9 B with Chinese biotech Hansoh for treatment of cardiometabolic diseases

Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, hav...Read more

- 23 December 2024 News


Australia
Australian startups receive $18.5 M to commercialise research to cure blindness, find cancer, and make childbirth safer


The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their r...Read more

- 23 December 2024 News


Korea
SK bioscience inks KRW 75.5 B deal with Sanofi to develop next-gen pneumococcal conjugate vaccines


South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...Read more

- 23 December 2024 News


North America
USFDA gives Orphan Drug Designation and Rare Paediatric Disease Designation to Aptamer developed in Hong Kong


A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to S...Read more

- 23 December 2024 News





All you want to read on

North America Europe Asia Pacific
South East Asia SAARC Middle East



This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2020 MM ACTIV. All rights reserved.
To Unsubscribe click here.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.